Skip to content
OpenCapital
Get started

Oric Pharmaceuticals, Inc. ORIC Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Pfizer logo
PfizerPFE
——
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
——
Arcus Biosciences logo
Arcus BiosciencesRCUS
——
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
——
Ethos Technologies, Inc. logo
Ethos Technologies, Inc. LIFE
——

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.4%
Enterprise value$923.07M+23.9%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0×0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s available for sale securities debt securities current?
Oric Pharmaceuticals, Inc. (ORIC) reported available for sale securities debt securities current of $225.54M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s available for sale securities debt securities current changed year-over-year?
Oric Pharmaceuticals, Inc.'s available for sale securities debt securities current increased by 46.1% year-over-year, from $154.39M to $225.54M.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s available for sale securities debt securities current?
Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s available for sale securities debt securities current has grown at a 1.9% compound annual growth rate (CAGR), from $215.15M to $235.82M.